Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosnodenvir in Confirmed Dengue Fever
NCT04906980Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosnodenvir in dengue fever, sponsored by Janssen Pharmaceutical. Started Jan 2022; status: terminated.
02
Drugs
mosnodenvir
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04906980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906980.